Singapore payment license Archives

30MayMay 30, 2022

EN#0143 – Singapore payment license-exempt for sale

A payment services license-exempt entity in...

By SALVUS TeamNewsfor sale, MAS, Monetary Authority Singapore, Payment Services Act, Payment services license-exempt, PSA, Regulated entity, Singapore, Singapore payment license

Members of the Global Institute of Internal Auditors (IIA). Member of the Cyprus Institute of Internal Auditors (Cyprus IIA) Research and Training Committee. Members of the Cyprus Investment Funds Association (CIFA) and the Association’s Fintech Committee. Member of the Cyprus Blockchain Technologies (CyBT) think-tank. Certified Actuarial Analyst (CAA) by the Institute and Faculties of Actuaries (IFoA). Certified Persons and Certified Anti-Money Laundering (AML) Officers in the Public Register of the Cyprus Securities and Exchange Commission (CySEC). Instructors on Compliance, Regulation & Internal Audit at the Institute for Professional Excellence (IforPE).

SALVUS Funds Licensing, Compliance & Internal Audit is the fastest-growing Regulatory Compliance boutique advisory for CFD brokers, EMI, payment institutions, investment funds, and crypto-asset services providers (CASP). As a premium brand, we are committed to elevating the communication of developments in the jurisdictions we service through all relevant channels using the #StayAhead, #WeAreSALVUS, #YouAreSALVUS, and #GrowWithSALVUS hashtags we created and consistently use them where applicable. We coined the trade marks of Business Athletes™ to refer to potential career candidates with us and our clients and The Most Complete™ series of regulatory compliance online courses.

SALVUS Funds is protected under two registered European trade marks. The trade mark registration numbers for the logo and the word mark are 018854839 and 018854882, respectively. These trade marks are protected under the European Union’s legislation.

SALVUSFunds Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission (license no. 225/196).